Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-134687
Filing Date
2017-04-24
Accepted
2017-04-24 16:35:57
Documents
3
Period of Report
2017-06-08
Effectiveness Date
2017-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d368901ddef14a.htm DEF 14A 383736
2 GRAPHIC g368901g57i48.jpg GRAPHIC 22171
3 GRAPHIC g368901g83n03.jpg GRAPHIC 27118
  Complete submission text file 0001193125-17-134687.txt   453045
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36332 | Film No.: 17778601
SIC: 2834 Pharmaceutical Preparations